Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Defesche

Showing results (111-120 of 178) with videos related to

Pageof 18
Sort By:
BMC Neurology|March 21, 2014
Arm hand skilled performance in cerebral palsy: activity preferences and their movement componentsRyanne J M Lemmens, Yvonne J M Janssen-Potten, Annick A A Timmermans, et al.
Atherosclerosis|December 6, 2022
Use of Lipoprotein(a) to improve diagnosis and management in clinical familial hypercholesterolemiaTycho R Tromp, Shirin Ibrahim, Nick S Nurmohamed, et al.
Clinical Genetics|December 1, 1992
Detection of the Pro664-Leu mutation in the low-density lipoprotein receptor and its relation to lipoprotein(a) levels in patients with familial hypercholesterolemia of Dutch ancestry from The Netherlands and CanadaJ C Defesche, M A van de Ree, J J Kastelein, et al.
Atherosclerosis|July 31, 2024
LDLR variant classification for improved cardiovascular risk prediction in familial hypercholesterolemiaShirin Ibrahim, Merel L Hartgers, Laurens F Reeskamp, et al.
Journal of Clinical Lipidology|November 3, 2020
Corrigendum to "Efficacy of alirocumab in 1191 patients with a wide spectrum of mutations in genes causative for familial hypercholesterolemia" J Clin Lipidol 11 (2017) 1338-1346Joep C Defesche, Claudia Stefanutti, Gisle Langslet, et al.
Journal of Clinical Lipidology|October 2, 2017
Efficacy of alirocumab in 1191 patients with a wide spectrum of mutations in genes causative for familial hypercholesterolemiaJoep C Defesche, Claudia Stefanutti, Gisle Langslet, et al.
Journal of Medical Genetics|September 3, 2002
Parental attitude towards genetic testing for familial hypercholesterolaemia in childrenM A W Umans-Eckenhausen, F J Oort, K C M P Ferenschild, et al.
Ebiomedicine|October 23, 2020
Differential DNA methylation in familial hypercholesterolemiaLaurens F Reeskamp, Andrea Venema, Joao P Belo Pereira, et al.
Circulation|March 14, 1998
A common mutation in the lipoprotein lipase gene (N291S) alters the lipoprotein phenotype and risk for cardiovascular disease in patients with familial hypercholesterolemiaM E Wittekoek, S N Pimstone, P W Reymer, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 13, 1999
A frequent mutation in the lipoprotein lipase gene (D9N) deteriorates the biochemical and clinical phenotype of familial hypercholesterolemiaM E Wittekoek, E Moll, S N Pimstone, et al.
Pageof 18

Showing results (111-120 of 178) with videos related to

Sort By:
Pageof 18
BMC Neurology|March 21, 2014
Arm hand skilled performance in cerebral palsy: activity preferences and their movement componentsRyanne J M Lemmens, Yvonne J M Janssen-Potten, Annick A A Timmermans, et al.
Atherosclerosis|December 6, 2022
Use of Lipoprotein(a) to improve diagnosis and management in clinical familial hypercholesterolemiaTycho R Tromp, Shirin Ibrahim, Nick S Nurmohamed, et al.
Clinical Genetics|December 1, 1992
Detection of the Pro664-Leu mutation in the low-density lipoprotein receptor and its relation to lipoprotein(a) levels in patients with familial hypercholesterolemia of Dutch ancestry from The Netherlands and CanadaJ C Defesche, M A van de Ree, J J Kastelein, et al.
Atherosclerosis|July 31, 2024
LDLR variant classification for improved cardiovascular risk prediction in familial hypercholesterolemiaShirin Ibrahim, Merel L Hartgers, Laurens F Reeskamp, et al.
Journal of Clinical Lipidology|November 3, 2020
Corrigendum to "Efficacy of alirocumab in 1191 patients with a wide spectrum of mutations in genes causative for familial hypercholesterolemia" J Clin Lipidol 11 (2017) 1338-1346Joep C Defesche, Claudia Stefanutti, Gisle Langslet, et al.
Journal of Clinical Lipidology|October 2, 2017
Efficacy of alirocumab in 1191 patients with a wide spectrum of mutations in genes causative for familial hypercholesterolemiaJoep C Defesche, Claudia Stefanutti, Gisle Langslet, et al.
Journal of Medical Genetics|September 3, 2002
Parental attitude towards genetic testing for familial hypercholesterolaemia in childrenM A W Umans-Eckenhausen, F J Oort, K C M P Ferenschild, et al.
Ebiomedicine|October 23, 2020
Differential DNA methylation in familial hypercholesterolemiaLaurens F Reeskamp, Andrea Venema, Joao P Belo Pereira, et al.
Circulation|March 14, 1998
A common mutation in the lipoprotein lipase gene (N291S) alters the lipoprotein phenotype and risk for cardiovascular disease in patients with familial hypercholesterolemiaM E Wittekoek, S N Pimstone, P W Reymer, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 13, 1999
A frequent mutation in the lipoprotein lipase gene (D9N) deteriorates the biochemical and clinical phenotype of familial hypercholesterolemiaM E Wittekoek, E Moll, S N Pimstone, et al.
Pageof 18